For the Inventor, By the Inventor

Enter assignee name

Houston, TX, United States of America

Immunomet Therapeutics Inc.

USPTO Granted Patents = 17

EPO Patents = 7

Trademarks = 1

Forward Citations = 47

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Ji Sun Lee (14 out of 38 patents)

Sung Wuk Kim (13 out of 31 patents)

Hye Jin Heo (8 out of 10 patents)

4. Chang Hee Min (8 out of 9 patents)

5. Ju Hoon Oh (8 out of 9 patents)

6. Yong Eun Kim (8 out of 10 patents)

7. Hong Bum Lee (7 out of 9 patents)

8. Duck Kim (6 out of 8 patents)

9. Hong Woo Kim (6 out of 8 patents)

10. Se Hwan Park (6 out of 7 patents)

11. Ji Ae Kook (5 out of 5 patents)

12. Byung Kyu Oh (5 out of 5 patents)

13. Sung Soo Jun (4 out of 17 patents)

14. Woong Cho (3 out of 6 patents)

15. Young Woong Kim (3 out of 8 patents)

17 patents: Sort by Forward Citations

1. 12377061 - Composition for promoting hair growth comprising a guanine derivative (2025-08-05),

2. 11826324 - Pharmaceutical compositions for preventing or treating inflammatory disease, autoimmune disease, or combination thereof, and method for using same (2023-11-28),

3. 11572341 - Biguanide compound and use thereof (2023-02-07),

4. 11465989 - Guanidine compounds and use thereof (2022-10-11),

5. 10626085 - Biguanide compound and use thereof (2020-04-21),

6. 10590081 - Guanidine compounds and use thereof (2020-03-17),

7. 10376480 - Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient (2019-08-13),

8. 10252996 - N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same (2019-04-09),

9. 10221190 - Biguanide compounds and use thereof (2019-03-05),

10. 10058558 - Pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives as an ingredient for preventing or treating fibrosis (2018-08-28),

11. 9993446 - Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient (2018-06-12),

12. 9884821 - N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same (2018-02-06),

13. 9540325 - N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same (2017-01-10),

14. 9539238 - Pharmaceutical composition comprising a biguanide derivative as an active ingredient for preventing or treating glioblastoma (2017-01-10),

15. 9464042 - Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient (2016-10-11),

ImmunoMet Therapeutics Inc. is a biotechnology company focused on the development of innovative pharmaceuticals in the field of immunometabolism. Utilizing cutting-edge research and technology, ImmunoMet aims to discover and develop novel therapies that target key metabolic pathways in immune cells. With a mission to improve patient outcomes in various diseases, ImmunoMet is dedicated to advancing the field of immunometabolism through rigorous scientific investigation and strategic partnerships.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#305 in Houston, TX

#1,133 in Texas

#18,330 in US

#34,858 in the World

Houston, TX, United States of America

Immunomet Therapeutics Inc.

Forward Citations = 47

47 inventors:

Ji Sun Lee (14 out of 38 patents)

Sung Wuk Kim (13 out of 31 patents)

Hye Jin Heo (8 out of 10 patents)

4. Chang Hee Min (8 out of 9 patents)

5. Ju Hoon Oh (8 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…